- Home
- CMPX vs UHG Comparison
CMPX vs UHG Comparison
Compare CMPX & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- UHG
- Stock Information
- Founded
- CMPX 2014
- UHG 2004
- Country
- CMPX United States
- UHG United States
- Employees
- CMPX N/A
- UHG N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- UHG Homebuilding
- Sector
- CMPX Health Care
- UHG Consumer Discretionary
- Exchange
- CMPX Nasdaq
- UHG Nasdaq
- Market Cap
- CMPX 291.8M
- UHG 242.0M
- IPO Year
- CMPX N/A
- UHG N/A
- Fundamental
- Price
- CMPX $3.44
- UHG $4.23
- Analyst Decision
- CMPX Strong Buy
- UHG
- Analyst Count
- CMPX 8
- UHG 0
- Target Price
- CMPX $13.50
- UHG N/A
- AVG Volume (30 Days)
- CMPX 1.4M
- UHG 102.1K
- Earning Date
- CMPX 08-11-2025
- UHG 08-07-2025
- Dividend Yield
- CMPX N/A
- UHG N/A
- EPS Growth
- CMPX N/A
- UHG N/A
- EPS
- CMPX N/A
- UHG 0.10
- Revenue
- CMPX N/A
- UHG $445,963,017.00
- Revenue This Year
- CMPX N/A
- UHG N/A
- Revenue Next Year
- CMPX N/A
- UHG N/A
- P/E Ratio
- CMPX N/A
- UHG $44.28
- Revenue Growth
- CMPX N/A
- UHG 7.51
- 52 Week Low
- CMPX $1.27
- UHG $1.60
- 52 Week High
- CMPX $4.08
- UHG $6.93
- Technical
- Relative Strength Index (RSI)
- CMPX 62.85
- UHG 53.56
- Support Level
- CMPX $3.29
- UHG $4.05
- Resistance Level
- CMPX $3.52
- UHG $4.38
- Average True Range (ATR)
- CMPX 0.18
- UHG 0.25
- MACD
- CMPX 0.04
- UHG -0.03
- Stochastic Oscillator
- CMPX 81.68
- UHG 49.25
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.